SecurityESBA / Empire State Realty Op, L.P. (292102100)
IndustryReal Estate Investment Trusts
Institutional Owners36
Institutional Shares1,318,346 - 4.22%
Common Shares Outstanding331,245,609 shares (as of 2018-06-30)
Institutional Value$ 23,209,000 USD
Related FISK / Empire State Realty OP, L.P.
OGCP / Empire State Realty OP, L.P.

Institutional Stock Ownership and Shareholders

ESBA / Empire State Realty Op, L.P. Institutional Ownership

Empire State Realty Op, L.P. (NYSE:ESBA) has 36 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,318,346 shares. Largest shareholders include North Star Investment Management Corp., Puzo Michael J, Royal Bank Of Canada, Commonwealth Equity Services, Llc., Commonwealth Equity Services, Inc, M&r Capital Management Inc, Old Mission Capital, Llc, State Street Corp, Ropes Wealth Advisors Llc, and Woodmont Investment Counsel Llc.
Empire State Realty Op, L.P. (NYSE:ESBA) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 57,956 21,474 -62.95 1,186 438 -63.07
2017-02-15 13F-HR OLD MISSION CAPITAL, LLC 46,112 921
2018-07-12 13F-HR CHICAGO TRUST Co NA 22,903 22,903 0.00 384 391 1.82
2018-08-09 13F-HR Tortoise Investment Management, LLC 27,992 27,992 0.00 469 478 1.92
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 22,207 20,707 -6.75 372 354 -4.84
2018-07-24 13F-HR Cribstone Capital Management, LLC 29,758 21,758 -26.88 494 371 -24.90
2018-08-13 13F-HR Baird Financial Group, Inc. 15,000 15,000 0.00 249 256 2.81
2018-07-10 13F-HR COBIZ INVESTMENT MANAGEMENT, LLC 25,948 443
2017-05-03 13F-HR TIAA CREF TRUST CO FSB/MO 17,383 25,986 49.49 347 539 55.33
2018-07-10 13F-HR COBIZ INVESTMENT MANAGEMENT, LLC 21,874 12,909 -40.98 373 221 -40.75
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 21,474 57,956 169.89 443 1,186 167.72
2018-07-20 13F-HR North Star Investment Management Corp. 94,631 10,737 -88.65 1,617 183 -88.68
2018-08-14 13F-HR LPL Financial LLC 23,774 20,548 -13.57 399 351 -12.03
2018-08-14 13F-HR UBS Group AG 13,563 6,663 -50.87 232 114 -50.86
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 22,110 14,938 -32.44 377 255 -32.36
2018-07-10 13F-HR COBIZ INVESTMENT MANAGEMENT, LLC 25,948 21,874 -15.70 443 373 -15.80
2018-08-10 13F-HR WOODMONT INVESTMENT COUNSEL LLC 36,147 36,147 0.00 606 618 1.98
2018-07-09 13F-HR YHB Investment Advisors, Inc. 10,937 21,474 96.34 182 366 101.10
2018-07-20 13F-HR North Star Investment Management Corp. 10,737 94,631 781.35 178 1,617 808.43
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 10,299 0 -100.00 173 0 -100.00
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 21,474 58,351 171.73 356 997 180.06
2018-08-13 13F-HR Advisor Group, Inc. 12,030 32,204 167.70 200 550 175.00
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 714 23,296 3,162.75 12 398 3,216.67
2018-08-14 13F-HR ROYAL BANK OF CANADA 21,474 10,937 -49.07 366 187 -48.91
2018-08-09 13F-HR Cowen Prime Services LLC 12,904 12,904 0.00 216 221 2.31
2018-08-14 13F-HR UBS Group AG 6,663 5,253 -21.16 114 90 -21.05
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 0 11,044 0 188
2018-08-14 13F-HR DEUTSCHE BANK AG\ 466 0 -100.00 7 0 -100.00
2018-07-30 13F-HR PUZO MICHAEL J 82,573 78,573 -4.84 1,384 1,343 -2.96
2018-08-01 13F-HR J. L. Bainbridge & Co., Inc. 17,206 294
2018-08-14 13F-HR STATE STREET CORP 45,922 45,345 -1.26 770 775 0.65
2018-07-20 13F-HR Tiaa, Fsb 25,986 13,038 -49.83 444 222 -50.00
2018-08-13 13F-HR Stratos Wealth Partners, LTD. 5,469 0 -100.00 91 0 -100.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 67,929 21,474 -68.39 1,161 366 -68.48
2018-08-14 13F-HR MORGAN STANLEY 27,067 3,807 -85.93 463 66 -85.75
2017-10-26 13F-HR Acrospire Investment Management LLC 492 0 -100.00 10 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 10,466 22,110 111.26 174 377 116.67
2018-07-24 13F-HR ACADIAN ASSET MANAGEMENT LLC 32,012 26,587 -16.95 538 454 -15.61
2018-08-14 13F-HR MORGAN STANLEY 3,702 27,067 631.15 63 463 634.92
2018-08-10 13F-HR YorkBridge Wealth Partners, LLC 8,603 8,603 0.00 140 147 5.00
2018-07-20 13F-HR Tiaa, Fsb 13,038 25,986 99.31 216 444 105.56
2018-08-14 13F-HR ROYAL BANK OF CANADA 10,937 67,929 521.09 182 1,161 537.91
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 23,296 7,796 -66.54 398 133 -66.58
2017-02-15 13F-HR OLD MISSION CAPITAL, LLC 46,112 31,257 -32.22 921 625 -32.14
2017-08-07 13F-HR Geneva Advisors, LLC 16,249 337
2018-08-08 13F-HR M&R CAPITAL MANAGEMENT INC 47,984 47,984 0.00 804 820 1.99
2018-08-13 13F-HR Advisor Group, Inc. 32,204 12,030 -62.64 550 205 -62.73
2018-08-08 13F-HR/A MONTAG A & ASSOCIATES INC 10,737 10,737 0.00 178 183 2.81
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 7,796 714 -90.84 133 12 -90.98
2018-08-14 13F-HR UBS Group AG 3,963 13,563 242.24 66 232 251.52
2018-07-09 13F-HR YHB Investment Advisors, Inc. 21,474 10,937 -49.07 366 187 -48.91
2018-07-11 13F-HR TRUST CO OF VERMONT 3,000 3,000 0.00 50 51 2.00
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 15,794 15,794 0.00 265 270 1.89
2018-08-14 13F-HR MORGAN STANLEY 3,807 300 -92.12 66 6 -90.91
2018-08-10 13F-HR ROPES WEALTH ADVISORS LLC 42,948 8,603 -79.97 733 147 -79.95
2018-07-20 13F-HR Creative Planning 15,706 15,706 0.00 263 268 1.90
2018-08-10 13F-HR ROPES WEALTH ADVISORS LLC 8,603 42,948 399.22 144 733 409.03
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 8,810 0 -100.00 148 0 -100.00
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 58,351 21,474 -63.20 997 366 -63.29
2018-08-03 13F-HR Fusion Family Wealth LLC 8,745 8,745 0.00 147 149 1.36
2017-05-03 13F-HR TIAA CREF TRUST CO FSB/MO 25,986 13,038 -49.83 539 267 -50.46

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 292102100